M01AC02 - Tenoxicam |
Probably not porphyrinogenic |
PNP |
Rationale
Substrate of CYP2C9. Two references consider it (probably) safe for use.
Chemical description
Tablet; 20 mg/d. Analgesic with antipyretic och anti-inflammatory effects for short-time treatment of light to moderate pain. Oxicam derivative extensively metabolized (CYP2C9), mainly to the 5-hydroxyderivative. Inhibitor of CYP2C9.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | French List
Centre Français des Porphyries
|
|
| 2. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames